Similar articles for PMID: 15800005

Year	Number of Results
1973	1
1983	1
1997	1
2000	2
2002	1
2003	1
2004	6
2005	12
2006	13
2007	13
2008	13
2009	12
2010	11
2011	14
2012	9
2013	10
2014	5
2015	9
2016	5
2017	6
2018	3
2019	2
2020	1
2022	3
2024	0

1

A comparison of the diagnostic accuracy and prognostic value of the first and second anti-cyclic citrullinated peptides (CCP1 and CCP2) autoantibody tests for rheumatoid arthritis.

van Gaalen FA, Visser H, Huizinga TW. van Gaalen FA, et al. Ann Rheum Dis. 2005 Oct;64(10):1510-2. doi: 10.1136/ard.2004.035089. Epub 2005 Mar 30. Ann Rheum Dis. 2005. PMID: 15800005 Free PMC article.

2

Anti-cyclic citrullinated peptide positivity in non-rheumatoid arthritis disease samples: citrulline-dependent or not?

Vannini A, Cheung K, Fusconi M, Stammen-Vogelzangs J, Drenth JP, Dall'Aglio AC, Bianchi FB, Bakker-Jonges LE, van Venrooij WJ, Pruijn GJ, Zendman AJ. Vannini A, et al. Ann Rheum Dis. 2007 Apr;66(4):511-6. doi: 10.1136/ard.2006.058933. Epub 2006 Sep 19. Ann Rheum Dis. 2007. PMID: 16984940 Free PMC article.

3

Serial determination of cyclic citrullinated peptide autoantibodies predicted five-year radiological outcomes in a prospective cohort of patients with early rheumatoid arthritis.

Meyer O, Nicaise-Roland P, Santos MD, Labarre C, Dougados M, Goupille P, Cantagrel A, Sibilia J, Combe B. Meyer O, et al. Arthritis Res Ther. 2006;8(2):R40. doi: 10.1186/ar1896. Epub 2006 Jan 26. Arthritis Res Ther. 2006. PMID: 16469118 Free PMC article.

4

Clinical evaluation of anti-mutated citrullinated vimentin by ELISA in rheumatoid arthritis.

Soós L, Szekanecz Z, Szabó Z, Fekete A, Zeher M, Horváth IF, Dankó K, Kapitány A, Végvári A, Sipka S, Szegedi G, Lakos G. Soós L, et al. J Rheumatol. 2007 Aug;34(8):1658-63. Epub 2007 Jul 1. J Rheumatol. 2007. PMID: 17611988

5

Antibodies against citrullinated vimentin in rheumatoid arthritis: higher sensitivity and extended prognostic value concerning future radiographic progression as compared with antibodies against cyclic citrullinated peptides.

Mathsson L, Mullazehi M, Wick MC, Sjöberg O, van Vollenhoven R, Klareskog L, Rönnelid J. Mathsson L, et al. Arthritis Rheum. 2008 Jan;58(1):36-45. doi: 10.1002/art.23188. Arthritis Rheum. 2008. PMID: 18163519 Free article.

6

Autoantibody profiling as early diagnostic and prognostic tool for rheumatoid arthritis.

Nell VP, Machold KP, Stamm TA, Eberl G, Heinzl H, Uffmann M, Smolen JS, Steiner G. Nell VP, et al. Ann Rheum Dis. 2005 Dec;64(12):1731-6. doi: 10.1136/ard.2005.035691. Epub 2005 May 5. Ann Rheum Dis. 2005. PMID: 15878904 Free PMC article.

7

Autoantibodies to cyclic citrullinated peptide 2 (CCP2) are superior to other potential diagnostic biomarkers for predicting rheumatoid arthritis in early undifferentiated arthritis.

Kudo-Tanaka E, Ohshima S, Ishii M, Mima T, Matsushita M, Azuma N, Harada Y, Katada Y, Ikeue H, Umeshita-Sasai M, Miyatake K, Saeki Y. Kudo-Tanaka E, et al. Clin Rheumatol. 2007 Oct;26(10):1627-33. doi: 10.1007/s10067-007-0558-5. Epub 2007 Feb 8. Clin Rheumatol. 2007. PMID: 17286215

8

Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.

van der Linden MP, van der Woude D, Ioan-Facsinay A, Levarht EW, Stoeken-Rijsbergen G, Huizinga TW, Toes RE, van der Helm-van Mil AH. van der Linden MP, et al. Arthritis Rheum. 2009 Aug;60(8):2232-41. doi: 10.1002/art.24716. Arthritis Rheum. 2009. PMID: 19644872 Free article.

9

Radiological outcome in rheumatoid arthritis is predicted by presence of antibodies against cyclic citrullinated peptide before and at disease onset, and by IgA-RF at disease onset.

Berglin E, Johansson T, Sundin U, Jidell E, Wadell G, Hallmans G, Rantapää-Dahlqvist S. Berglin E, et al. Ann Rheum Dis. 2006 Apr;65(4):453-8. doi: 10.1136/ard.2005.041376. Epub 2005 Sep 21. Ann Rheum Dis. 2006. PMID: 16176994 Free PMC article.

10

Diagnostic performance of anti-citrullinated peptide antibodies for the diagnosis of rheumatoid arthritis: the relevance of likelihood ratios.

Pietrapertosa D, Tolusso B, Gremese E, Papalia MC, Bosello SL, Peluso G, Petricca L, Michelutti A, Faustini F, Fedele AL, Ferraccioli G. Pietrapertosa D, et al. Clin Chem Lab Med. 2010 Jun;48(6):829-34. doi: 10.1515/CCLM.2010.152. Clin Chem Lab Med. 2010. PMID: 20298138

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

127 results

Results by year